Trial
NCT00925119
Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Diabetes Mellitus, Type 2
Intervention
Atenolol
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-26